Anthropometric and metabolic parameters associated with visceral fat in non-obese type 2 diabetes individuals

被引:0
|
作者
Jiao, Ming [1 ,2 ]
Chen, Jiaoli [1 ]
Wang, Xiaoling [1 ]
Tao, Wenyu [1 ]
Feng, Yunhua [1 ]
Yang, Huijun [1 ]
Yang, Haiying [1 ]
Zhao, Shanshan [1 ]
Yang, Ying [1 ]
Li, Yiping [1 ]
机构
[1] Yunnan Univ, Peoples Hosp Yunnan Prov 2, Affiliated Hosp, Dept Endocrinol, Kunming 650021, Yunnan, Peoples R China
[2] Kunming Med Univ, Kunming 650021, Yunnan, Peoples R China
来源
DIABETOLOGY & METABOLIC SYNDROME | 2025年 / 17卷 / 01期
关键词
T2DM; Visceral fat; Relevant factors; Normal BMI; Neck circumference; Lipid accumulation product; LIPID-ACCUMULATION PRODUCT; CAROTID-ARTERY INTIMA; BODY-MASS INDEX; NECK CIRCUMFERENCE; ADIPOSITY INDEX; INSULIN-RESISTANCE; MEDIA THICKNESS; CENTRAL OBESITY; RISK-FACTORS; DISEASE;
D O I
10.1186/s13098-025-01583-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and Aim Visceral fat (VF) was proved to be a more precise predictor of atherosclerotic cardiovascular disease (ASCVD) risk in individuals with type 2 diabetes mellitus (T2DM) than body mass index (BMI) itself. Even when the BMI was normal, visceral fat area (VFA) >= 90 cm(2) could raise the ten-year risk of developing ASCVD. Therefore, it was worth evaluating the association of influencing factors with high VF in non-obese T2DM individuals. Methods This study enrolled 1,409 T2DM participants with T2DM, of whom 538 had a normal BMI. Based on VFA, these subjects were divided into two groups: VF (+) (VFA >= 90cm(2)) (n = 110) and VF (-) (VFA < 90cm(2)) (n = 428). The measurement of VFA was conducted using an Omron VF measuring device. Anthropometric and metabolic parameters were detected. Novel insulin resistance indices, such as lipid accumulation product (LAP) was calculated. Factors associated with VF were screened using univariate analysis, multifactorial binary logistic regression models and chi-squared automatic interaction detector decision tree model. Results The VF (+) OB (-) (BMI <= 23.9 kg/m(2)) prevalence were 7.8% in T2DM subjects (n = 1,409) and 20.4% in T2DM subjects with normal BMI (n = 538), respectively. In T2DM subjects with normal BMI, the logistic regression model suggested that neck circumference (NC) had an odds ratio (OR) of 1.891 (95% CI: 1.165-3.069, P = 0.010). The OR for VF gradually increased from the 1st to the 4th in LAP quartile (P < 0.05). LAP emerged as the root node, followed by NC in the decision tree model. Receiver operating characteristic curve (ROC) analysis demonstrated that the area under the curve (AUC) for NC in predicting high VF levels was 0.640 for males and 0.682 for females. Optimal NC cut-off points were 37.75 cm for males and 34.75 cm for females, respectively. Additionally, the AUC values of LAP in predicting high VF levels were 0.745 for males and 0.772 for females, with optimal LAP cut-off points of 22.64 and 26.45 for males and females, respectively. Conclusion This study identified NC and LAP can be considered predictors of high VF in T2DM subjects with normal BMI.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Role of Metabolic Surgery in Less Obese or Non-Obese Subjects with Type 2 Diabetes: Influence Over Cardiovascular Events
    Ricardo Cohen
    Pedro Paulo Caravatto
    Tarissa Petry
    David Cummings
    Current Atherosclerosis Reports, 2013, 15
  • [32] Role of Metabolic Surgery in Less Obese or Non-Obese Subjects with Type 2 Diabetes: Influence Over Cardiovascular Events
    Cohen, Ricardo
    Caravatto, Pedro Paulo
    Petry, Tarissa
    Cummings, David
    CURRENT ATHEROSCLEROSIS REPORTS, 2013, 15 (10)
  • [33] Ipragliflozin Reduces Epicardial Fat Accumulation in Non-Obese Type 2 Diabetic Patients with Visceral Obesity: A Pilot Study
    Tatsuya Fukuda
    Ryotaro Bouchi
    Masahiro Terashima
    Yuriko Sasahara
    Masahiro Asakawa
    Takato Takeuchi
    Yujiro Nakano
    Masanori Murakami
    Isao Minami
    Hajime Izumiyama
    Koshi Hashimoto
    Takanobu Yoshimoto
    Yoshihiro Ogawa
    Diabetes Therapy, 2017, 8 : 851 - 861
  • [34] Ipragliflozin Reduces Epicardial Fat Accumulation in Non-Obese Type 2 Diabetic Patients with Visceral Obesity: A Pilot Study
    Fukuda, Tatsuya
    Bouchi, Ryotaro
    Terashima, Masahiro
    Sasahara, Yuriko
    Asakawa, Masahiro
    Takeuchi, Takato
    Nakano, Yujiro
    Murakami, Masanori
    Minami, Isao
    Izumiyama, Hajime
    Hashimoto, Koshi
    Yoshimoto, Takanobu
    Ogawa, Yoshihiro
    DIABETES THERAPY, 2017, 8 (04) : 851 - 861
  • [35] Association of circulating adipokines with metabolic dyslipidemia in obese versus non-obese individuals
    Rahimlou, Mehran
    Mirzaei, Khadijeh
    Keshavarz, Seyed Ali
    Hossein-Nezhad, Arash
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2016, 10 (01) : S60 - S65
  • [36] Clinical features and risk factors associated with NAFLD in non-obese type 2 diabetes patients
    Ichikawa, Takeshi
    Oi, Itaru
    Fujino, Masayuki A.
    HEPATOLOGY, 2017, 66 : 1139A - 1139A
  • [37] EXPRESSION OF ANXIETY ASSOCIATED WITH HYPERGLYCERIDEMIA IN OBESE INDIVIDUALS AND NON-OBESE SUBJECTS
    SEGERS, MJ
    MERTENS, C
    VASTESAEGER, M
    JOURNAL OF PSYCHOSOMATIC RESEARCH, 1975, 19 (03) : 169 - 182
  • [39] Similar incretin secretion in obese and non-obese Japanese subjects with type 2 diabetes
    Kozawa, Junji
    Okita, Kohei
    Imagawa, Akihisa
    Iwahashi, Hiromi
    Holst, Jens J.
    Yamagata, Kazuya
    Shimomura, Iichiro
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 393 (03) : 410 - 413
  • [40] Ectopic and Visceral Fat Deposition in Lean and Obese Patients With Type 2 Diabetes
    Levelt, Eylem
    Pavlides, Michael
    Banerjee, Rajarshi
    Mahmod, Masliza
    Kelly, Catherine
    Sellwood, Joanna
    Ariga, Rina
    Thomas, Sheena
    Francis, Jane
    Rodgers, Christopher
    Clarke, William
    Sabharwal, Nikant
    Antoniades, Charalambos
    Schneider, Jurgen
    Robson, Matthew
    Clarke, Kieran
    Karamitsos, Theodoros
    Rider, Oliver
    Neubauer, Stefan
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (01) : 53 - 63